The DOI matches its Crossref record; 95 of the 95 references it cites were found in a registry or an index.
Classification of scaffold-hopping approaches
Open accessAbstract
The general goal of drug discovery is to identify novel compounds that are active against a preselected biological target with acceptable pharmacological properties defined by marketed drugs. Scaffold hopping has been widely applied by medicinal chemists to discover equipotent compounds with novel backbones that have improved properties. In this review, scaffold hopping is classified into four major categories, namely heterocycle replacements, ring opening or closure, peptidomimetics, and topology-based hopping. The structural diversity of original and final scaffolds with respect to each category will be reviewed. The advantages and limitations of small, medium, and large-step scaffold hopping will also be discussed. Software that is frequently used to facilitate different kinds of scaffold hopping methods will be summarized.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Cambridge Structural Database: a quarter of a million crystal structures and rising
Allen, F. H. (2002) · Acta Crystallographica Section B Structural Science · doi:10.1107/s0108768102003890 · Cited by 9,898
Green, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,965
International Union of Pharmacology: Approaches to the Nomenclature of Voltage-Gated Ion Channels
Catterall, W. A., Chandy, K. G., Clapham, D. E., Gutman, G. A., Hofmann, F., Harmar, A. J., Abernethy, D. R., & Spedding, M. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.4.5 · Cited by 7,126
In Vivo Activation of the p53 Pathway by Small-Molecule Antagonists of MDM2
Vassilev, L. T., Vu, B. T., Graves, B., Carvajal, D., Podlaski, F., Filipovic, Z., Kong, N., Kammlott, U., Lukacs, C., Klein, C., et al. (2004) · Science · doi:10.1126/science.1092472 · Cited by 4,661
Escape from Flatland: Increasing Saturation as an Approach to Improving Clinical Success
Lovering, F., Bikker, J., & Humblet, C. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901241e · Cited by 4,495
ChEMBL: a large-scale bioactivity database for drug discovery
Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., Light, Y., McGlinchey, S., Michalovich, D., Al-Lazikani, B., et al. (2012) · Nucleic Acids Research · doi:10.1093/nar/gkr777 · Cited by 4,382
ZINC − A Free Database of Commercially Available Compounds for Virtual Screening
Irwin, J. J., & Shoichet, B. K. (2005) · Journal of Chemical Information and Modeling · doi:10.1021/ci049714+ · Cited by 4,058
DrugBank: a comprehensive resource for in silico drug discovery and exploration
Wishart, D. S. (2006) · Nucleic Acids Research · doi:10.1093/nar/gkj067 · Cited by 3,892
Hopkins, A. L., & Groom, C. R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd892 · Cited by 3,305
International Union of Pharmacology. XXIII. The Angiotensin II Receptors
de Gasparo, M., Catt, K. J., Inagami, T., Wright, J. W., & Unger, T. (2000) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01458-3 · Cited by 2,132
BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities
Liu, T., Lin, Y., Wen, X., Jorissen, R. N., & Gilson, M. K. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl999 · Cited by 2,124
Ritchie, T. J., & Macdonald, S. J. F. (2009) · Drug Discovery Today · doi:10.1016/j.drudis.2009.07.014 · Cited by 901
Structural and biochemical basis of apoptotic activation by Smac/DIABLO
Chai, J., Du, C., Wu, J.-W., Kyin, S., Wang, X., & Shi, Y. (2000) · Nature · doi:10.1038/35022514 · Cited by 864
Do Structurally Similar Molecules Have Similar Biological Activity?
Martin, Y. C., Kofron, J. L., & Traphagen, L. M. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm020155c · Cited by 806
Inglese, J., Auld, D. S., Jadhav, A., Johnson, R. L., Simeonov, A., Yasgar, A., Zheng, W., & Austin, C. P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604348103 · Cited by 792
“Scaffold-Hopping” by Topological Pharmacophore Search: A Contribution to Virtual Screening
Schneider, G., Neidhart, W., Giller, T., & Schmid, G. (1999) · Angewandte Chemie International Edition · doi:10.1002/(sici)1521-3773(19991004)38:19<2894::aid-anie2894>3.0.co;2-f · Cited by 717
Ishikawa, M., & Hashimoto, Y. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101356p · Cited by 619
Converting a Peptide into a Drug: Strategies to Improve Stability and Bioavailability
Adessi, C., & Soto, C. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867024606731 · Cited by 614
Rush, T. S., Grant, J. A., Mosyak, L., & Nicholls, A. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm040163o · Cited by 600
Intramolecular Hydrogen Bonding in Medicinal Chemistry
Kuhn, B., Mohr, P., & Stahl, M. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100087s · Cited by 571
Peptidomimetics, a synthetic tool of drug discovery
Vagner, J., Qu, H., & Hruby, V. J. (2008) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2008.03.009 · Cited by 538
MDM2 inhibitors for cancer therapy
Vassilev, L. T. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2006.11.002 · Cited by 532
COX-2 and beyond: approaches to prostaglandin inhibition in human disease
FitzGerald, G. A. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1225 · Cited by 518
Hale, C. A., & de Boer, P. A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81838-3 · Cited by 506
BACTERIAL CELL DIVISION AND THE Z RING
Lutkenhaus, J., & Addinall, S. G. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.93 · Cited by 465
Angiotensin AT1/AT2 Receptors: Regulation, Signalling and Function
KASCHINA, E., & UNGER, T. (2003) · Blood Pressure · doi:10.1080/08037050310001057 · Cited by 458
SVIZENSKA, I., DUBOVY, P., & SULCOVA, A. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.05.010 · Cited by 457
The druggable genome: an update
Russ, A. P., & Lampel, S. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03666-4 · Cited by 424
Gierse, J. K., McDonald, J. J., Hauser, S. D., Rangwala, S. H., Koboldt, C. M., & Seibert, K. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.26.15810 · Cited by 410
Huang, R., Southall, N., Wang, Y., Yasgar, A., Shinn, P., Jadhav, A., Nguyen, D.-T., & Austin, C. P. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3001862 · Cited by 401
Characteristic Physical Properties and Structural Fragments of Marketed Oral Drugs
Vieth, M., Siegel, M. G., Higgs, R. E., Watson, I. A., Robertson, D. H., Savin, K. A., Durst, G. L., & Hipskind, P. A. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030267j · Cited by 359
Wang, J. L., Limburg, D., Graneto, M. J., Springer, J., Hamper, J. R. B., Liao, S., Pawlitz, J. L., Kurumbail, R. G., Maziasz, T., Talley, J. J., et al. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.07.054 · Cited by 337
Böhm, H.-J., Flohr, A., & Stahl, M. (2004) · Drug Discovery Today: Technologies · doi:10.1016/j.ddtec.2004.10.009 · Cited by 335
Heteroaromatic Rings of the Future
Pitt, W. R., Parry, D. M., Perry, B. G., & Groom, C. R. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801513z · Cited by 332
Orner, B. P., Ernst, J. T., & Hamilton, A. D. (2001) · Journal of the American Chemical Society · doi:10.1021/ja0025548 · Cited by 320
An overview of the PubChem BioAssay resource
Wang, Y., Bolton, E., Dracheva, S., Karapetyan, K., Shoemaker, B. A., Suzek, T. O., Wang, J., Xiao, J., Zhang, J., & Bryant, S. H. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkp965 · Cited by 295
Lee, M.-L., & Schneider, G. (2001) · Journal of Combinatorial Chemistry · doi:10.1021/cc000097l · Cited by 293
Lee, E. F., Czabotar, P. E., Smith, B. J., Deshayes, K., Zobel, K., Colman, P. M., & Fairlie, W. D. (2007) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4402178 · Cited by 278
CAVEAT: A program to facilitate the design of organic molecules
Lauri, G., & Bartlett, P. A. (1994) · Journal of Computer-Aided Molecular Design · doi:10.1007/bf00124349 · Cited by 266
Apoptosis: target of cancer therapy.
Ferreira, C. G., Epping, M. T., Kruyt, F. A. E., & Giaccone, G. (2002) · PubMed · Cited by 265
Cox-2-Selective Inhibitors: The New Super Aspirins
DeWitt, D. L. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23023-6 · Cited by 261
Gans, K. R., Galbraith, W., Roman, R. J., Haber, S. B., Kerr, J. S., Schmidt, W. K., Smith, C., Hewes, W. E., & Ackerman, N. R. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)12610-4 · Cited by 231
Bioisosteric Replacement and Scaffold Hopping in Lead Generation and Optimization
Langdon, S. R., Ertl, P., & Brown, N. (2010) · Molecular Informatics · doi:10.1002/minf.201000019 · Cited by 224
Coxibs interfere with the action of aspirin by binding tightly to one monomer of cyclooxygenase-1
Rimon, G., Sidhu, R. S., Lauver, D. A., Lee, J. Y., Sharma, N. P., Yuan, C., Frieler, R. A., Trievel, R. C., Lucchesi, B. R., & Smith, W. L. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909765106 · Cited by 205
Sebhat, I. K., Martin, W. J., Ye, Z., Barakat, K., Mosley, R. T., Johnston, D. B. R., Bakshi, R., Palucki, B., Weinberg, D. H., MacNeil, T., et al. (2002) · Journal of Medicinal Chemistry · doi:10.1021/jm025539h · Cited by 193
Flexible Alignment of Small Molecules
Labute, P., Williams, C., Feher, M., Sourial, E., & Schmidt, J. M. (2001) · Journal of Medicinal Chemistry · doi:10.1021/jm0002634 · Cited by 192
ErG: 2D Pharmacophore Descriptions for Scaffold Hopping
Stiefl, N., Watson, I. A., Baumann, K., & Zaliani, A. (2006) · Journal of Chemical Information and Modeling · doi:10.1021/ci050457y · Cited by 190
Zhang, Q., & Muegge, I. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050468i · Cited by 182
p53 Activation by Small Molecules: Application in Oncology
Vassilev, L. T. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm058174k · Cited by 174
Research applications of the Cambridge Structural Database (CSD)
Allen, F. H., & Taylor, R. (2004) · Chemical Society Reviews · doi:10.1039/b309040j · Cited by 166
On Scaffolds and Hopping in Medicinal Chemistry
Brown, N., & Jacoby, E. (2006) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/138955706778742768 · Cited by 158
Scaffold‐Hopping: How Far Can You Jump?
Schneider, G., Schneider, P., & Renner, S. (2006) · QSAR & Combinatorial Science · doi:10.1002/qsar.200610091 · Cited by 150
Drug prototypes and their exploitation
(1997) · European Journal of Medicinal Chemistry · doi:10.1016/s0223-5234(97)84366-8 · Cited by 147
PubChem as a Source of Polypharmacology
Chen, B., Wild, D. J., & Guha, R. (2009) · Journal of Chemical Information and Modeling · doi:10.1021/ci9001876 · Cited by 142
Maaß, P. C., Schulz‐Gasch, T., Ståhl, M., & Rarey, M. (2007) · Journal of Chemical Information and Modeling · doi:10.1021/ci060094h · Cited by 141
Vucic, D., Franklin, M. C., Wallweber, H. J. A., Kanad, D. A. S., Eckelman, B. P., Shin, H., Elliott, L. O., Kadkhodayan, S., Deshayes, K., Salvesen, G. S., et al. (2004) · Biochemical Journal · doi:10.1042/bj20041108 · Cited by 136
A 3D Similarity Method for Scaffold Hopping from Known Drugs or Natural Ligands to New Chemotypes
Jenkins, J. L., Glick, M., & Davies, J. W. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049654z · Cited by 130
CRAMER, R. D. I., Jilek, R. J., Güssregen, S., Clark, S. J., Wendt, B., & Clark, R. D. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm049501b · Cited by 130
A Universal Molecular Descriptor System for Prediction of LogP, LogS, LogBB, and Absorption
Sun, H. (2004) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci030304f · Cited by 128
Self-citationBehavioural effects of histamine and its antagonists: a review
White, J. M., & Rumbold, G. (1988) · Psychopharmacology · doi:10.1007/bf00212757 · Cited by 125
Drug discovery in the next decade: innovation needed ASAP
Bennani, Y. L. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.06.004 · Cited by 120
Prospective Identification of Biologically Active Structures by Topomer Shape Similarity Searching
CRAMER, R. D. I., Poss, M. A., Hermsmeier, M. A., Caulfield, T. J., Kowala, M. C., & Valentine, M. T. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990159q · Cited by 104
Modulating apoptosis as a target for effective therapy
Fleischer, A., Ghadiri, A., Dessauge, F., Duhamel, M., Rebollo, M. P., Alvarez-Franco, F., & Rebollo, A. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2005.07.013 · Cited by 102
Panek, R. L., Lu, G. H., Klutchko, S. R., Batley, B. L., Dahring, T. K., Hamby, J. M., Hallak, H., Doherty, A. M., & Keiser, J. A. (1997) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37140-x · Cited by 96
Scaffold‐Hopping Potential of Ligand‐Based Similarity Concepts
Renner, S., & Schneider, G. (2005) · ChemMedChem · doi:10.1002/cmdc.200500005 · Cited by 93
5-HT2 receptor antagonists and migraine therapy
Mylecharane, E. J. (1991) · Journal of Neurology · doi:10.1007/bf01642906 · Cited by 83
Sañudo, M. C., García‐Valverde, M., Marcaccini, S., Delgado, J. J., Rojo, J., & Torroba, T. (2009) · The Journal of Organic Chemistry · doi:10.1021/jo8025862 · Cited by 77
Recent developments in de novo design and scaffold hopping.
Mauser, H., & Guba, W. (2008) · PubMed · Cited by 76
The scaffold hopping potential of pharmacophores
Heßler, G., & Baringhaus, K. (2010) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2010.09.001 · Cited by 72
Franke, L., Schwarz, O., Müller‐Kuhrt, L., Hoernig, C., Fischer, L., George, S., Tanrıkulu, Y., Schneider, P., Werz, O., Steinhilber, D., et al. (2007) · Journal of Medicinal Chemistry · doi:10.1021/jm060655w · Cited by 70
Evelyn, C. R., Bell, J. L., Ryu, J. G., Wade, S. M., Kocab, A. J., Harzdorf, N. L., Showalter, H. D., Neubig, R. R., & Larsen, S. D. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.11.056 · Cited by 67
Effectiveness of 2D Fingerprints for Scaffold Hopping
Gardiner, E. J., Holliday, J. D., O’Dowd, C., & Willett, P. (2011) · Future Medicinal Chemistry · doi:10.4155/fmc.11.4 · Cited by 66
Wassermann, A. M., & Bajorath, J. (2010) · Journal of Chemical Information and Modeling · doi:10.1021/ci1001845 · Cited by 64
Furet, P., Bold, G., Hofmann, F., Manley, P. W., Meyer, T., & Altmann, K. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00626-7 · Cited by 64
Rosenström, U., Sköld, C., Lindeberg, G., Botros, M., Nyberg, F., Karlén, A., & Hallberg, A. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030921v · Cited by 60
Oosterom, J., Nijenhuis, W. A. J., Schaaper, W. M. M., Slootstra, J. W., Meloen, R. H., Gispen, W. H., Burbach, J. P. H., & Adan, R. A. H. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.16853 · Cited by 60
Kinase Patent Space Visualization Using Chemical Replacements
Southall, N. T., & Ajay (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051201m · Cited by 56
Apoptosis: A Target for Neuroprotection
Charriaut‐Marlangue, C. (2004) · Therapies · doi:10.2515/therapie:2004035 · Cited by 54
Lawandi, J., Toumieux, S., Seyer, V., Campbell, P. D., Thielges, S., Juillerat‐Jeanneret, L., & Moitessier, N. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901013a · Cited by 49
Molecular shape and electrostatics in the encoding of relevant chemical information
Nicholls, A. O., & Grant, J. (2005) · Journal of Computer-Aided Molecular Design · doi:10.1007/s10822-005-9019-x · Cited by 43
Apoptosis: a potential target for discovering novel therapies for cardiovascular diseases
Yue, T., Ohlstein, E. H., & Ruffolo, R. R., Jr. (1999) · Current Opinion in Chemical Biology · doi:10.1016/s1367-5931(99)80069-6 · Cited by 43
Cohen, F., Alicke, B., Elliott, L. O., Flygare, J. A., Goncharov, T., Keteltas, S. F., Franklin, M. C., Frankovitz, S. M., Stéphan, J.-P., Tsui, V., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm801450c · Cited by 41
PubChem BioAssays as a data source for predictive models
Chen, B., & Wild, D. J. (2009) · Journal of Molecular Graphics and Modelling · doi:10.1016/j.jmgm.2009.10.001 · Cited by 39
Structure–activity based study of the Smac-binding pocket within the BIR3 domain of XIAP
Wist, A. D., Gu, L., Riedl, S. J., Shi, Y., & McLendon, G. L. (2007) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2007.02.010 · Cited by 38
Rosenström, U., Sköld, C., Lindeberg, G., Botros, M., Nyberg, F., Karlén, A., & Hallberg, A. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm051222g · Cited by 36
Drug prototypes and their exploitation
Timmerman, H. (1997) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(97)90638-6 · Cited by 35
Georgsson, J., Sköld, C., Plouffe, B., Lindeberg, G., Botros, M., Larhed, M., Nyberg, F., Gallo‐Payet, N., Gogoll, A., Karlén, A., et al. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm050280z · Cited by 32
Soter, N. A. (1990) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(05)80245-3 · Cited by 25
Beyond QSAR: Lead Hopping to Different Structures
Martin, Y. C., & Muchmore, S. W. (2009) · QSAR & Combinatorial Science · doi:10.1002/qsar.200810176 · Cited by 24
Eastwood, P. R., González, J., Paredes, S., Fonquerna, S., Cardús, A., Alonso, J. A., Nueda, A., Domènech, T., Reinoso, R. F., & Vidal, B. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.01.077 · Cited by 21
Fujisaka, Y., Yamada, Y., Yamamoto, N., Shimizu, T., Fujiwara, Y., Yamada, K., Tamura, T., Watanabe, H., Sun, Y., Bass, M., et al. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1243-y · Cited by 21
SHOP: A Method For Structure‐Based Fragment and Scaffold Hopping
Fontaine, F., Cross, S., Plasencia, G., Pastor, M., & Zamora, I. (2009) · ChemMedChem · doi:10.1002/cmdc.200800355 · Cited by 19
Sun, H., Greeley, D. N., Chu, X., Cheung, A. W., Danho, W., Swistok, J., Wang, Y., Zhao, C., Chen, L., & Fry, D. C. (2004) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2004.03.017 · Cited by 18
Self-citationMolecular Modeling of Melanocortin Receptors
Sun, H., & Fry, D. C. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/156802607780906573 · Cited by 6
Self-citationNIH Program to Boost Pipeline for Drugs to Treat Rare and Neglected Diseases
Kuehn, B. M. (2009) · JAMA · doi:10.1001/jama.2009.940 · Cited by 3
Cited by
Bacterial Biofilm Eradication Agents: A Current Review
Verderosa, A. D., Totsika, M., & Fairfull-Smith, K. E. (2019) · Frontiers in Chemistry · doi:10.3389/fchem.2019.00824 · Cited by 555
Put a ring on it: application of small aliphatic rings in medicinal chemistry
Bauer, M. R., Di Fruscia, P., Lucas, S. C. C., Michaelides, I. N., Nelson, J. E., Storer, R. I., & Whitehurst, B. C. (2021) · RSC Medicinal Chemistry · doi:10.1039/d0md00370k · Cited by 479
Mäder, P., & Kattner, L. (2020) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c00960 · Cited by 438
Recent Advances in Scaffold Hopping: Miniperspective
Hu, Y., Stumpfe, D., & Bajorath, J. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b01437 · Cited by 361
Improving compound–protein interaction prediction by building up highly credible negative samples
Liu, H., Sun, J., Guan, J., Zheng, J., & Zhou, S. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv256 · Cited by 359
Metadata
- Authors
- Sun, H., Tawa, G., & Wallqvist, A.
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2012-04
- Volume
- 17
- Issue
- 7-8
- Pages
- 310-324
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2067300585
- Cited by
- 375
- References
- 95
- FWCI
- 11.66
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.